Newman Dignan & Sheerar, Inc. - Q2 2015 holdings

$139 Million is the total value of Newman Dignan & Sheerar, Inc.'s 145 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was - .

 Value Shares↓ Weighting
TAPA NewMolson Coors Brewing$778,00011,145
+100.0%
0.56%
L NewLowes Companies$520,0007,762
+100.0%
0.37%
PRGO NewPerrigo Co plc$510,0002,758
+100.0%
0.37%
WDC NewWestern Digital Corp$355,0004,526
+100.0%
0.26%
SYNA NewSynaptics Inc$344,0003,965
+100.0%
0.25%
UTHR NewUnited Therapeutics Corp$343,0001,969
+100.0%
0.25%
TGT NewTarget Corp$308,0003,772
+100.0%
0.22%
SNI NewScripps Networks Interactiveetf$305,0004,665
+100.0%
0.22%
NewAir Prods & Chems$246,0001,800
+100.0%
0.18%
RAD NewRite Aid Corp$243,00029,100
+100.0%
0.18%
ABBV NewAbbVie Inc$232,0003,447
+100.0%
0.17%
A309PS NewDIRECTV$230,0002,476
+100.0%
0.17%
AMLP NewAlerian MLP ETFetf$213,00013,696
+100.0%
0.15%
DEO NewDiageo Plc$208,0001,794
+100.0%
0.15%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-07-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Schwab Dow Jones US Div Eq ETF42Q3 20236.6%
Schwab Dow Jones US Large Cap ETF42Q3 20237.3%
Schwab Dow Jones US Large Growth ETF42Q3 20234.9%
Schwab Dow Jones US Large Value ETF42Q3 20234.5%
Apple, Inc42Q3 202320.8%
Schwab Dow Jones US Sm-Cap ETF42Q3 202313.5%
Microsoft Corp42Q3 20233.4%
Johnson & Johnson42Q3 20232.9%
Novartis A G42Q3 202356.8%
Merck & Co Inc42Q3 20232.5%

View Newman Dignan & Sheerar, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-29
13F-HR2024-02-09
13F-HR2023-11-08
13F-HR2023-08-02
13F-HR2023-04-28
13F-HR2023-01-20
13F-HR2022-10-18
13F-HR2022-08-03
13F-HR2022-04-14
13F-HR2022-01-18

View Newman Dignan & Sheerar, Inc.'s complete filings history.

Compare quarters

Export Newman Dignan & Sheerar, Inc.'s holdings